Indian pharma
GST reforms, RDI scheme strengthened Indian pharma in 2025, innovation & access key for 2026
Indian pharma and healthcare sector witnessed $3.5 billion deals in Q3 2025: Report
US tariffs not a bitter pill for Indian pharma makers
US pharma tariffs a headline risk for Sun Pharma: Report
Indian pharma sector will not suffer any loss due to Trump tariff: Former ICMR chief